CoChat

Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S‐Ketamine and Less on Intravenous S‐Ketamine

Open access
Peltoniemi, Marko A., Saari, Teijo I., Hagelberg, Nora M., Laine, Kari, Kurkinen, Kaisa J., Neuvonen, Pertti J., Olkkola, Klaus T. · 2012 · Basic & Clinical Pharmacology & Toxicology
Cited by 56

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Low‐dose ketamine is currently used in several acute and chronic pain conditions as an analgesic. Ketamine undergoes extensive metabolism and is thus susceptible to drug–drug interactions. We examined the effect rifampicin, a well‐known inducer of many cytochrome P450 (CYP) enzymes and transporters, on the pharmacokinetics of intravenous and oral S‐ketamine in healthy volunteers. Eleven healthy volunteers were administered in randomized order 600 mg rifampicin or placebo orally for 6 days in a four‐session paired cross‐over study. On day 6, S‐ketamine was administered intravenously (0.1 mg/kg) in the first part of the study and orally (0.3 mg/kg) in the second part. Plasma concentrations of ketamine and norketamine were measured up to 24 hr and behavioural and analgesic effects up to 12 hr. Rifampicin treatment decreased the mean area under the plasma ketamine concentration–time curve extrapolated to infinity (AUC 0–∞) of intravenous and oral S‐ketamine by 14% (p = 0.005) and 86% (p < 0.001), respectively. Rifampicin decreased greatly the peak plasma concentration of oral S‐ketamine by 81% (p < 0.001), but shortened only moderately the elimination half‐life of intravenous and oral S‐ketamine. Rifampicin decreased the ratio of norketamine AUC 0–∞ to ketamine AUC 0–∞ after intravenous S‐ketamine by 66%, (p < 0.001) but increased the ratio by 147% (p < 0.001) after the oral administration of S‐ketamine. Rifampicin profoundly reduces the plasma concentrations of ketamine and norketamine after oral administration of S‐ketamine, by inducing mainly its first‐pass metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-7843.2012.00908.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 56

Metadata

Authors
Peltoniemi, M. A., Saari, T. I., Hagelberg, N. M., Laine, K., Kurkinen, K. J., Neuvonen, P. J., & Olkkola, K. T.
Venue
Basic & Clinical Pharmacology & Toxicology
Publisher
Wiley
Published
2012-06-27
Volume
111
Issue
5
Pages
325-332
ISSN
  • 1742-7835 (ISSN-L)
  • 1742-7843
OpenAlex
W2072055545
Cited by
56
References
2
FWCI
2.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S‐Ketamine and Less on Intravenous S‐Ketamine. https://app.cochat.ai/papers/10.1111/j.1742-7843.2012.00908.x
The paper
Peltoniemi, M. A., Saari, T. I., Hagelberg, N. M., Laine, K., Kurkinen, K. J., Neuvonen, P. J., & Olkkola, K. T. (2012). Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S‐Ketamine and Less on Intravenous S‐Ketamine. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/j.1742-7843.2012.00908.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.